United States Cellular Corporation 5.500% Senior Notes due 2070
United States Cellular Corporation 5.500% Senior Notes due 2070 (UZF) Financial Performance & Income Statement Overview
Explore the financials of United States Cellular Corporation 5.500% Senior Notes due 2070 (UZF), including yearly and quarterly data on income, cash flow, and balance sheets.
United States Cellular Corporation 5.500% Senior Notes due 2070 (UZF) Income Statement & Financial Overview
Analyze United States Cellular Corporation 5.500% Senior Notes due 2070’s UZF earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $970.00M | $922.00M | $927.00M | $950.00M |
| Cost of Revenue | $276.00M | $383.00M | $577.00M | $585.00M |
| Gross Profit | $694.00M | $539.00M | $350.00M | $365.00M |
| Gross Profit Ratio | $0.72 | $0.58 | $0.38 | $0.38 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $353.00M | $324.00M | $301.00M | $309.00M |
| Operating Expenses | $703.00M | $629.00M | $301.00M | $309.00M |
| Total Costs & Expenses | $979.00M | $1.01B | $878.00M | $894.00M |
| Interest Income | $3.00M | $4.00M | $3.00M | $2.00M |
| Interest Expense | $46.00M | $49.00M | $45.00M | $43.00M |
| Depreciation & Amortization | $182.00M | $170.00M | $186.00M | $187.00M |
| EBITDA | $122.00M | $145.00M | $263.00M | $243.00M |
| EBITDA Ratio | $0.13 | $0.16 | $0.25 | $0.26 |
| Operating Income | -$9.00M | -$90.00M | $49.00M | $56.00M |
| Operating Income Ratio | -$0.009 | -$0.10 | $0.05 | $0.06 |
| Other Income/Expenses (Net) | -$5.00M | -$2.00M | -$4.00M | -$4.00M |
| Income Before Tax | -$14.00M | -$92.00M | $32.00M | $52.00M |
| Income Before Tax Ratio | -$0.01 | -$0.10 | $0.03 | $0.05 |
| Income Tax Expense | -$19.00M | -$14.00M | $14.00M | $28.00M |
| Net Income | $5.00M | -$79.00M | $17.00M | $18.00M |
| Net Income Ratio | $0.005 | -$0.09 | $0.02 | $0.02 |
| EPS | $0.06 | -$0.92 | $0.20 | $0.21 |
| Diluted EPS | $0.06 | -$0.92 | $0.19 | $0.20 |
| Weighted Avg Shares Outstanding | $85.00M | $86.00M | $86.00M | $85.00M |
| Weighted Avg Shares Outstanding (Diluted) | $88.00M | $86.00M | $88.00M | $88.00M |
Financial performance has remained strong, with revenue growing from $950.00M in Q1 2024 to $970.00M in Q4 2024. Gross profit continued to perform well, with margins at 72% in the latest quarter. Operating income reached -$9.00M in Q4 2024, holding a steady -1% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $122.00M. Net income rose to $5.00M, keeping EPS at $0.06. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan